Marek Pluta

1.2k total citations
25 papers, 904 citations indexed

About

Marek Pluta is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Marek Pluta has authored 25 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Obstetrics and Gynecology, 13 papers in Reproductive Medicine and 10 papers in Epidemiology. Recurrent topics in Marek Pluta's work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (10 papers). Marek Pluta is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (10 papers). Marek Pluta collaborates with scholars based in Czechia, Switzerland and Germany. Marek Pluta's co-authors include Lukáš Rob, Helena Robová, Petr Škapa, M Halaška, Pavel Strnad, M. Hrehorčák, Roman Chmel, Martin Charvát, Jiří Lisý and Ivana Malá and has published in prestigious journals such as Journal of Clinical Oncology, Transplantation and Genomics.

In The Last Decade

Marek Pluta

23 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Pluta Czechia 17 684 408 344 344 180 25 904
Adriana Bermúdez Argentina 8 789 1.2× 519 1.3× 258 0.8× 356 1.0× 287 1.6× 16 1.0k
Kanishka Karunaratne Sri Lanka 4 511 0.7× 342 0.8× 197 0.6× 216 0.6× 142 0.8× 7 697
Shinichiro Minobe Japan 16 562 0.8× 194 0.5× 222 0.6× 385 1.1× 231 1.3× 50 821
Amandine Maulard France 15 590 0.9× 240 0.6× 245 0.7× 545 1.6× 180 1.0× 54 904
Mauricio Cuello Fredes Chile 2 498 0.7× 319 0.8× 158 0.5× 207 0.6× 129 0.7× 3 673
Helena Robová Czechia 22 1.2k 1.7× 723 1.8× 601 1.7× 678 2.0× 288 1.6× 61 1.5k
Sara Imboden Switzerland 20 955 1.4× 256 0.6× 106 0.3× 762 2.2× 243 1.4× 90 1.3k
J. A. Lejárcegui Spain 13 422 0.6× 159 0.4× 87 0.3× 351 1.0× 185 1.0× 21 674
Elly Brockbank United Kingdom 13 337 0.5× 91 0.2× 196 0.6× 415 1.2× 194 1.1× 24 692
Neil S. Horowitz United States 17 680 1.0× 187 0.5× 103 0.3× 512 1.5× 161 0.9× 29 854

Countries citing papers authored by Marek Pluta

Since Specialization
Citations

This map shows the geographic impact of Marek Pluta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Pluta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Pluta more than expected).

Fields of papers citing papers by Marek Pluta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Pluta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Pluta. The network helps show where Marek Pluta may publish in the future.

Co-authorship network of co-authors of Marek Pluta

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Pluta. A scholar is included among the top collaborators of Marek Pluta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Pluta. Marek Pluta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rob, Lukáš, David Cibula, Paweł Knapp, et al.. (2022). Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial. Journal for ImmunoTherapy of Cancer. 10(1). e003190–e003190. 31 indexed citations
2.
Major, Attila, et al.. (2021). Correction to: Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial. Archives of Gynecology and Obstetrics. 303(2). 513–514. 8 indexed citations
3.
4.
Major, Attila, et al.. (2020). Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial. Archives of Gynecology and Obstetrics. 303(2). 501–511. 14 indexed citations
5.
Nováčková, Marta, M Halaška, Ivana Malá, et al.. (2014). A Prospective Study in the Evaluation of Quality of Life After Vulvar Cancer Surgery. International Journal of Gynecological Cancer. 25(1). 166–173. 29 indexed citations
6.
Robová, Helena, M Halaška, Marek Pluta, et al.. (2014). Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecologic Oncology. 135(2). 213–216. 75 indexed citations
7.
Ehrlichová, Marie, Beatrice Mohelníková-Duchoňová, Jiří Hrdý, et al.. (2013). The association of taxane resistance genes with the clinical course of ovarian carcinoma. Genomics. 102(2). 96–101. 27 indexed citations
8.
Robová, Helena, Lukáš Rob, M Halaška, Marek Pluta, & Petr Škapa. (2012). Current status of sentinel lymph node mapping in the management of endometrial cancer. Expert Review of Anticancer Therapy. 13(1). 55–61. 48 indexed citations
9.
Robová, Helena, Lukáš Rob, M Halaška, et al.. (2012). High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer. Gynecologic Oncology. 128(1). 49–53. 37 indexed citations
10.
Nováčková, Marta, M Halaška, Helena Robová, et al.. (2012). A Prospective Study in Detection of Lower-Limb Lymphedema and Evaluation of Quality of Life After Vulvar Cancer Surgery. International Journal of Gynecological Cancer. 22(6). 1081–1088. 34 indexed citations
11.
Halaška, M, Marta Nováčková, Ivana Malá, et al.. (2010). A Prospective Study of Postoperative Lymphedema After Surgery for Cervical Cancer. International Journal of Gynecological Cancer. 20(5). 900–904. 30 indexed citations
12.
Rob, Lukáš, Marek Pluta, Petr Škapa, & Helena Robová. (2010). Advances in fertility-sparing surgery for cervical cancer. Expert Review of Anticancer Therapy. 10(7). 1101–1114. 15 indexed citations
13.
Robová, Helena, Michael J. Halaška, Marek Pluta, et al.. (2010). The Role of Neoadjuvant Chemotherapy and Surgery in Cervical Cancer. International Journal of Gynecological Cancer. 20(11 Suppl 2). S42–S46. 35 indexed citations
14.
Pluta, Marek, Lukáš Rob, Martin Charvát, et al.. (2009). Less radical surgery than radical hysterectomy in early stage cervical cancer – A pilot study. Gynecologic Oncology. 113(2). 181–184. 79 indexed citations
15.
Rob, Lukáš, Helena Robová, Marek Pluta, & Petr Škapa. (2009). Fertilitu zachovávající postupy u časných stadií karcinomů děložního hrdla. 3(1). 39–43. 1 indexed citations
16.
Rob, Lukáš, Marek Pluta, Pavel Strnad, et al.. (2008). A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer. Gynecologic Oncology. 111(2). S116–S120. 125 indexed citations
17.
Strnad, Pavel, Helena Robová, Petr Škapa, et al.. (2008). A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer. Gynecologic Oncology. 109(2). 280–284. 72 indexed citations
18.
Rob, Lukáš, et al.. (2007). Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. International Journal of Gynecological Cancer. 17(1). 147–153. 43 indexed citations
19.
Rob, Lukáš, Pavel Strnad, Helena Robová, et al.. (2005). Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecologic Oncology. 98(2). 281–288. 122 indexed citations
20.
Rob, Lukáš, Martin Charvát, Helena Robová, et al.. (2005). Sentinel lymph node identification (SLNI) in the management of conservative surgery in early cervical cancer: Is it acceptable?. Gynecologic Oncology. 99(3). S147–S148. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Bermúdez Breakdown of academic impact, for papers by Kanishka Karunaratne Breakdown of academic impact, for papers by Shinichiro Minobe Breakdown of academic impact, for papers by Amandine Maulard Breakdown of academic impact, for papers by Mauricio Cuello Fredes Breakdown of academic impact, for papers by Helena Robová Breakdown of academic impact, for papers by Sara Imboden Breakdown of academic impact, for papers by J. A. Lejárcegui Breakdown of academic impact, for papers by Elly Brockbank Breakdown of academic impact, for papers by Neil S. Horowitz
Rankless by CCL
2026